Skin-Test Sign-Off Time Dropped Sharply: What Changed in a Real Clinic

The Sign-Off Bottleneck

Skin testing generates more discrete data points per visit than almost any other allergy procedure. Every allergen. Every wheal diameter. Every flare grade. Controls documented first. Read times recorded. Then the interpretation, the patient education, the immunotherapy discussion—and finally, the sign-off.

For the allergist, sign-off means reviewing what the nurse recorded, cross-checking borderline readings, confirming the panel makes clinical sense, and signing the encounter. It's not optional. It's not delegable. And when the testing schedule is full, those unsigned encounters stack up.

The documentation is necessary. The bottleneck is real. And until recently, no one had a good answer for how to make sign-off faster without cutting corners.

What Happened at Allergy Affiliates

Allergy Affiliates ran a 60-day pilot testing whether AI could assist with skin-test documentation while keeping the allergist in control of every clinical decision. The goal was not to automate sign-off—it was to reduce the time the provider spent per encounter without compromising accuracy or clinical judgment.

In that pilot, the time an allergist spends signing off each skin-test visit dropped sharply.

What changed? But the clinician confirmed every value. The allergist signed. Nothing went into the record without human review.

What the AI Handled

The nurse photographed the test sites at the read time. The system proposed wheal sizes and grades for each allergen. It flagged ambiguous readings—wheals near the borderline, flares that might need a second look, controls that didn't behave as expected.

It did not interpret. It did not decide what the panel meant for the patient's immunotherapy plan. It proposed. The clinician confirmed or corrected.

For straightforward panels—clear positives, clear negatives, good controls—the draft was often accurate enough that the provider's review took seconds. For ambiguous cases, the system surfaced the uncertainty, and the clinician made the call. When the nurse wasn't confident in a reading, they could mark it for manual measurement, and the allergist handled it the traditional way.

The AI never replaced clinical judgment. It reduced the manual transcription and data entry that came before judgment.

What Stayed Human

Every value in the signed record came from a human decision. The nurse confirmed each proposed reading. The allergist reviewed the full panel, saw the photos alongside the drafted results, and signed only when satisfied.

Borderline wheals—those at the threshold where clinical significance changes—were flagged for provider review. Ambiguous flares, weak histamine controls, or saline reactivity triggered an alert. The system did not guess. It asked.

When the clinician disagreed with a proposed value, they corrected it. The AI's role was to draft, not to decide.

This is investigational technology. It is not FDA-cleared. It is in daily clinical use at Allergy Affiliates because the workflow keeps the clinician as the final authority on every data point.

Why Sign-Off Time Dropped

The time savings came from three places.

First, the allergist no longer transcribed wheal sizes from the nurse's handwritten sheet into the EMR. The drafted panel was already structured and ready for review.

Second, the photos were visible alongside the drafted values during sign-off. The provider could spot-check any reading without leaving the review screen or asking the nurse to recall what they saw.

Third, the system flagged the cases that needed extra attention. Clear-cut panels moved quickly. Ambiguous cases got the time they deserved. The allergist's attention went where it mattered.

The pilot did not measure minutes saved per encounter. What it showed was that allergists could clear their sign-off queue faster, with confidence that every value was clinician-confirmed.

The Workflow in Practice

The nurse applies the panel, waits for the read time, and photographs the test sites. The system drafts the results. The nurse reviews each proposed wheal size and flare grade on a tablet, confirms or corrects, and submits.

The encounter moves to the allergist's sign-off queue. The provider sees the drafted panel, the photos, and any flagged readings. They review, make any changes, and sign. The signed results flow to the patient's chart.

Every step has a human gate. The nurse confirms the draft. The allergist signs the record. The AI does not make clinical decisions—it structures the data so the clinician can.

What This Means for Allergy Practices

Skin testing is one of the highest-volume, highest-documentation-burden procedures in allergy practice. Reducing sign-off time without sacrificing accuracy means allergists can see more patients, leave the office earlier, or spend more time on complex cases that need it.

The Allergy Affiliates pilot suggests that AI assistance—when designed with clinician confirmation at every step—can make sign-off faster and less tedious. It does not eliminate the allergist's role. It eliminates the transcription, the data entry, and the hunting through handwritten notes that came before the clinical review.

This is not about replacing clinical judgment. It is about giving allergists back the time they currently spend on clerical work, so they can focus on the judgment itself.

Medora is the AI Copilot built only for allergy practices. Not FDA-cleared. The system is in daily clinical use at Allergy Affiliates.

Because all Medora modules share one patient context, the skin-test results the nurse recorded are available to the visit note when the allergist reviews it. The system does not silo testing data—it makes it available wherever the clinician needs it.

Providers can see the workflow in action at https://medoramd.ai/demo.html.

Engagement Question

How does your practice handle skin-test sign-off today—and where does the time go?

---

Medora Scribe, built for allergy visits. Medora Copilot listens to the allergy visit and drafts an allergy-structured SOAP note, with visit templates for new patients, follow-ups, skin testing, immunotherapy and asthma. The clinician reviews, edits and signs every note. See how Medora Scribe works or start a 14-day free trial, no card needed ($99 per provider per month after the trial).